NCT06577974 Role of Medical Treatment in Endometriosis Patients Undergoing ICSI
| NCT ID | NCT06577974 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Endometriosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 129 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2025-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 129 participants in total. It began in 2024-07-01 with a primary completion date of 2025-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study to assess the effect of medical treatment prior to stimulation on fertility (ICSI) outcome in cases with endometriosis associated infertility.
Eligibility Criteria
Inclusion Criteria: * Presence of Endometrioma on ultrasound. * History of ovarian cystectomy either open or via laparoscopic surgery. * Presence of endometriotic foci in the pelvis during laparoscopic surgery. * Patients coming for the first ICSI / IVF cycle. Exclusion Criteria: * Age above 40 years * Cases with endometrioma on ultrasound more than 3 cm size. * Prior failed ICSI / IVF. * Known poor responders or poor ovarian reserve, defined as AFC\<5 or AMH \< 0.5 . * Patients with previous uterine surgery. * Patients diagnosed to have uterine abnormalities
Contact & Investigator
Ahmed Taha, Professor
STUDY CHAIR
Cairo University
Frequently Asked Questions
Who can join the NCT06577974 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 40 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06577974 currently recruiting?
Yes, NCT06577974 is actively recruiting participants. Contact the research team at zdawoud9@gmail.com for enrollment information.
Where is the NCT06577974 trial being conducted?
This trial is being conducted at Cairo, Egypt, Cairo, Egypt.
Who is sponsoring the NCT06577974 clinical trial?
NCT06577974 is sponsored by Cairo University. The principal investigator is Ahmed Taha, Professor at Cairo University. The trial plans to enroll 129 participants.